WCAS is the leading private equity investor in our two growth
industries of information/business services and healthcare. Our
target industries are very large and are projected to total $6.5
trillion in 2013, representing approximately 40% of U.S. GDP.
We believe our domain industry knowledge, developed over 34
years, dramatically improves our ability to (i) source and close
transactions, (ii) conduct more effective due diligence, (iii)
recruit seasoned management teams, (iv) identify operating
improvements, (v) capture synergies across the portfolio and (vi)
take advantage of inefficiencies in the capital
We utilize a top-down approach to sourcing and evaluating deals.
WCAS completes in-depth reviews of all the subsectors within
our two core industries; identifies potential acquisition
candidates; and focuses on ways to better source transactions to
build a strong deal pipeline.
WCAS is well known for creating leading companies within its
target industries. There are over 40 current or former public
companies in our two core industries that can trace their roots to
WCAS. The combined market capitalization of these companies exceeds
$145 billion. Examples of former WCAS information/business services
portfolio companies include (i) Alliance Data Systems Corporation
(ADS); (ii) Amdocs Limited (DOX); (iii) Bisys; (iv) Card
Establishment Services, which merged into First Data; (v) ComData,
which was acquired by Ceridian, and (vi) Fiserv, Inc. (FISV).
Examples of current or former WCAS healthcare companies include (i)
Accuro, which was acquired by MedAssets (MDAS); (ii) AGA Medical,
which was acquired by St. Jude Medical (STJ); (iii) Accredo Health,
which was acquired by Medco Health Solutions; (iv) AmeriPath and
LabOne, which were acquired by Quest Diagnostics (DGX); (v)
Magella, which was acquired by MEDNAX (MD); (vi) Quorum Health
Group Inc., which was merged into Triad Hospitals; (vii) Select
Medical Corporation (SEM) and (viii) US Oncology, which was
acquired by McKesson (MCK).